Kazia Therapeutics Limited (KZIA)

Kazia Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	4.35	1.66	5.24	7.36	27.59
Cash & Short-Term Investments	4.35	1.66	5.24	7.36	27.59
Cash Growth	162.22%	-68.38%	-28.80%	-73.32%	214.77%
Accounts Receivable	-	-	0	-	-
Other Receivables	0.09	0.13	0.1	0.05	0.08
Receivables	0.09	0.13	0.11	0.05	0.08
Prepaid Expenses	0.49	0.59	1.63	2	1.72
Other Current Assets	0.01	3.76	3.79	0.04	0.01
Total Current Assets	4.93	6.15	10.77	9.45	29.39
Other Intangible Assets	1.09	15.4	17.27	19.14	22
Other Long-Term Assets	0.04	0.04	0.04	7.3	6.69
Total Assets	6.06	21.59	28.08	35.89	58.09
Accounts Payable	5.65	4.55	0.86	1.52	1.89
Accrued Expenses	4.86	10.88	4.16	2.6	3.27
Short-Term Debt	0.4	0.63	1.8	1.84	-
Other Current Liabilities	3.15	9.73	0.75	0.76	3.16
Total Current Liabilities	14.05	25.8	7.57	6.73	8.33
Pension & Post-Retirement Benefits	0.04	0.04	0.06	0.12	0.05
Long-Term Deferred Tax Liabilities	0.27	2.02	2.29	2.56	2.93
Other Long-Term Liabilities	-	3.75	6.12	8.21	8.93
Total Liabilities	14.36	31.6	16.03	17.61	20.24
Common Stock	123.05	101.64	97.45	84.48	80.29
Retained Earnings	-134.83	-115.13	-89.08	-68.62	-44.2
Comprehensive Income & Other	3.48	3.48	3.68	2.41	1.76
Total Common Equity	-8.3	-10.02	12.05	18.27	37.85
Shareholders' Equity	-8.3	-10.02	12.05	18.27	37.85
Total Liabilities & Equity	6.06	21.59	28.08	35.89	58.09
Total Debt	0.4	0.63	1.8	1.84	-
Net Cash (Debt)	3.95	1.02	3.45	5.52	27.59
Net Cash Growth	286.02%	-70.30%	-37.59%	-79.99%	214.77%
Net Cash Per Share	3.60	1.94	9.35	20.84	117.22
Filing Date Shares Outstanding	1.83	0.87	0.47	0.3	0.26
Total Common Shares Outstanding	1.62	0.67	0.46	0.28	0.26
Working Capital	-9.12	-19.65	3.21	2.72	21.06
Book Value Per Share	-5.13	-15.05	26.42	65.85	143.36
Tangible Book Value	-9.39	-25.42	-5.22	-0.86	15.85
Tangible Book Value Per Share	-5.80	-38.18	-11.44	-3.11	60.03

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q